Dr Andargachew Kumsa is a Medical Doctor and a public health expert specializing in TB, Drug Resistant TB and TB/HIV. He is trained in Ethiopia (Addis Ababa University Faculty of Medicine and University of Gondar). Currently, he works as a Senior Drug Resistant TB Advisor to the National TB Control Program of Ethiopia through the USAID STAR Project providing an embedded technical support in DR-TB Programming. Over the past 15 years, he has developed extensive experience in TB, TB/HIV and DR-TB programming, technical leadership, research and TB/DR-TB program management. He has served as a senior TB/HIV advisor to the national TB control program at the Ministry of Health and as the NTP manager overseeing the design and the implementations of all facets of the National TB control program in Ethiopia. He has served as a country representative of Partners In Health in Ethiopia, an international medical organization and led the design and implementation of the Unitaid funded endTB Project, one of the most consequential projects aimed at introducing the new drugs (Bedaquiline and Delamanid) for management of DR-TB patients under programmatic and operational research conditions in Ethiopia. He has spearheaded the development of national implementation plan and framework for introduction of new TB drugs in Ethiopia. The endTB project that he has led laid the foundation for the establishment of a multi-disciplinary and multi-specialty Clinical Review Committee (CRC), a mechanism established to provide comprehensive specialized care services to DR-TB patients thereby improving the outcome of DR-TB patients. He has served as a co-secretary of the national CRC. Based on the lessons obtained from the CRC support during the project period, the NTP has expanded the CRC mechanisms to regions as a sustainable system to improve the quality of DR-TB care in Ethiopia. He has led the development of national TB, TB/HIV and DR-TB Strategies, guidelines and policies. He has led the development of two successive national TB Strategic plans (TB NSPS) along with the coordination of several external TB NSP reviews both for Ethiopia and several other countries in Africa. He is well versed with the latest global policies, strategies and guidelines on TB, TB/HIV, and DR-TB. Dr Andargachew has also an extensive experience in Global Fund processes from funding request preparations to grant making including grant negotiations and implementation. He served as the key member of the GF funding writing team for Ethiopia since 2012. He has worked on several proposals on TB, TB/HIV, DR-TB and Health System Strengthening programs and mobilized resources from several donors including USAID, PEPFAR, Unitaid, WHO and others.
Dr Andargachew has an extensive experience in capacity building of health program managers and health care providers. He has trained the Ethiopian Health Workforce on Clinical and programmatic management of TB, TB/HIV and DR-TB for over a decade. He has also extended his support on DR-TB as GLC consultant to WHO supporting several African countries on DR-TB management and programming. He has co-authored several research papers on TB, TB/HIV and DR-TB that were published in international Journals. His career goal is to contribute to the realization of a TB-free world the improved and equitable access to high-quality TB/DR-TB services to all.